Tag: SCAI 2017

State of the art in TAVR

By

SCAI 2017 Highlights

By

Cath Lab Boot Camp

By

State of the art in CPV

By

Origins and Future of the PE Response Team

Dr. Kenneth Rosenfield and Dr. C. Michael Gibson Discuss

Message from the Outgoing SCAI President

Dr. Kenneth Rosenfield and Dr. C. Michael Gibson Discuss

Take-Aways from the Cardio-Oncology Workshop

Dr. Kostas Marmagkiolis, Dr. Cezar Iliescu and Dr. C. Michael Gibson Discuss

PLATINUM DIVERSITY Outcomes and SCAI Women in Innovations

Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss

Interventional Coronary Physiology: A 30-Year Overnight Success Story

Dr. Morton Kern and Dr. C. Michael Gibson Discuss

State of the Art in Transseptal Therapies

Dr. Zoltan Turi, Dr. George Hanzel and Dr. C. Michael Gibson Discuss

Top Sessions for Cardiovascular Professionals at SCAI 2017

Jeff Davis, Bernadette Speiser, Rena Silver and Dr. C. Michael Gibson Discuss

Opportunities and Challenges for the Cardiovascular Interventionalists

Dr. Christopher White and Dr. C. Michael Gibson Discuss

SCAI’s New Executive Director

Francesca Dea and Dr. C. Michael Gibson Discuss

Intersection of Coronary Artery Disease and TAVR

Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

Pediatric Interventional Cardiology: Alice in Wonderland or Fred Astaire and Ginger Rogers?

Dr. Lee Benson and Dr. C. Michael Gibson Discuss

Pediatric VSD: What Is It?

Dr. Evan Zahn and Dr. C. Michael Gibson Discuss